Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients

Abstract : In this study we evaluated the potential of expanded NK cells (eNKs) from two sources combined with the mAbs daratumumab and pembrolizumab to target primary multiple myeloma (MM) cells ex vivo. In order to ascertain the best source of NK cells, we expanded and activated NK cells from peripheral blood (PB) of healthy adult donors and from umbilical cord blood (UCB). The resulting expanded NK (eNK) cells express CD16, necessary for carrying out antibody-dependent cellular cytotoxicity (ADCC). Cytotoxicity assays were performed on bone marrow aspirates of 18 MM patients and 4 patients with monoclonal gammopathy of undetermined significance (MGUS). Expression levels of PD-1 on eNKs and PD-L1 on MM and MGUS cells were also quantified. Results indicate that most eNKs obtained using our expansion protocol express a low percentage of PD-1+ cells. UCB eNKs were highly cytotoxic against MM cells and addition of daratumumab or pembrolizumab did not further increase their cytotoxicity. PB eNKs, while effective against MM cells, were significantly more cytotoxic when combined with daratumumab. In a minority of cases, eNK cells showed a detectable population of PD1+ cells. This correlated with low cytotoxic activity, particularly in UCB eNKs. Addition of pembrolizumab did not restore their activity. Results indicate that UCB eNKs are to be preferentially used against MM in the absence of daratumumab while PB eNKs have significant cytotoxic advantage when combined with this mAb.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.umontpellier.fr/hal-03163825
Contributeur : Anthony Herrada Connectez-vous pour contacter le contributeur
Soumis le : mardi 9 mars 2021 - 14:45:38
Dernière modification le : vendredi 22 octobre 2021 - 14:58:49
Archivage à long terme le : : jeudi 10 juin 2021 - 19:10:57

Fichier

Expanded NK cells from umbilic...
Fichiers éditeurs autorisés sur une archive ouverte

Licence


Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale 4.0 International License

Identifiants

Collections

`

Citation

Chantal Reina-Ortiz, Michael Constantinides, Alexis Fayd-Herbe-De-Maudave, Jessy Présumey, Javier Hernandez, et al.. Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients. OncoImmunology, Taylor & Francis, 2021, 10 (1), pp.1853314. ⟨10.1080/2162402X.2020.1853314⟩. ⟨hal-03163825⟩

Partager

Métriques

Consultations de la notice

34

Téléchargements de fichiers

67